The European Patent Office (EPO) has granted patent EP3870698B1, titled 'Antipathogenic Polypeptides,' effective March 18, 2026. The patent, assigned to inventors Bryan W. Berger and Evan L. Eckersley, relates to novel polypeptide sequences designed to combat pathogens and their use in various applications, including cleaning compositions.

This patent grant signifies a new intellectual property right in the field of biotechnology and pharmaceuticals. Companies operating in this sector, particularly those involved in developing antimicrobial agents or cleaning products, should review the patent claims to ensure their products or research do not infringe upon this granted IP. No immediate compliance actions are required for entities outside of those directly involved in the development or commercialization of the patented technology.